Phibro Animal Health | PAHC - Sales Revenues


Phibro Animal Health reported $309.26M in Sales Revenues for its fiscal quarter ending in December of 2024.





Sales Change Date
Align Technology USD 1.05B 54.3M Dec/2025
ANI Pharmaceuticals USD 247.06M 19.25M Dec/2025
Assertio Holdings USD 29.2M 1.92M Sep/2024
Aurora Cannabis CAD 90.37M 7.65M Sep/2025
Bristol-Myers Squibb USD 12.5B 300M Dec/2025
Canopy Growth CAD 66.68M 5.45M Sep/2025
Corcept Therapeutics USD 202.12M 5.48M Dec/2025
Eli Lilly USD 19.3B 1.7B Dec/2025
Henry Schein USD 3.4B 60M Dec/2025
Idexx Laboratories USD 1.09B 10M Dec/2025
Knight Therapeutics CAD 92.26M 3.31M Sep/2024
Merck USD 16.4B 880M Dec/2025
Nektar Therapeutics USD 24.12M 635K Sep/2024
Pacira USD 196.87M 17.35M Dec/2025
Phibro Animal Health USD 309.26M 48.83M Dec/2024
Prestige Brands USD 283.44M 9.34M Dec/2025
Supernus Pharmaceuticals USD 211.6M 19.5M Dec/2025
Zoetis USD 2.4B 0 Dec/2025